{
    "clinical_study": {
        "@rank": "38314", 
        "arm_group": [
            {
                "arm_group_label": "Vitamin D", 
                "arm_group_type": "Experimental", 
                "description": "vitamin D-oral cholecalciferol 2000 IU/day for 4 months"
            }, 
            {
                "arm_group_label": "Physical activity", 
                "arm_group_type": "Active Comparator", 
                "description": "A 3-day/week exercise programme lasting 60 minutes each day for 4 months was instigated."
            }, 
            {
                "arm_group_label": "Vitamin D and Physical activity", 
                "arm_group_type": "Experimental", 
                "description": "Vitamin D -oral cholecalciferol 2000 IU/day and Physical activity-60-minute 3-day/week exercise programme"
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "The control group was provided with health education using videotaped presentations, physician talks on topics concerning bone and muscle health."
            }
        ], 
        "brief_summary": {
            "textblock": "In the present study the aim was to determine the prevalence of sarcopenia and to evaluate\n      the effectiveness of an exercise program and vitamin D supplementation in enhancing muscle\n      mass and strength in community-dwelling older adults with osteopenia /osteoporosis.\n\n      One hundred and forty-five individuals aged 65 years and above with documented\n      osteopenia/osteoporosis were scanned for sarcopenia. The participants were randomly assigned\n      to one of four groups: Group 1-PA and vitamin D (n= 38), Group 2-PA(n=36), Group 3-vitamin D\n      (n= 36) or Group 4-healthy lifestyle(n =35) for 16 weeks. The PA group received a 60-minute\n      3-day/week exercise programme, the vitamin D group received oral cholecalciferol 2000 IU/day\n      and the control group was provided with health education using videotaped presentations,\n      physician talks on topics concerning bone and muscle health. Body composition was measured\n      DEXA. Vitamin D levels were measured and PA was measured using the Baecke Physical Activity\n      Questionnaire. Physical performance was assessed using upper limb grip strength, walking\n      speed and knee extension strength. All data was collected at baseline and at 4 months."
        }, 
        "brief_title": "Vitamin D and Physical Activity for Prevention of Sarcopenia in Osteoporosis", 
        "completion_date": {
            "#text": "September 2011", 
            "@type": "Actual"
        }, 
        "condition": "Sarcopenia", 
        "condition_browse": {
            "mesh_term": [
                "Osteoporosis", 
                "Sarcopenia"
            ]
        }, 
        "detailed_description": {
            "textblock": "Ageing is associated with changes in body composition and due to the ageing of the\n      populations and the lessened physical activity (PA), sarcopenia and osteopenia /osteoporosis\n      are emerging as major health concerns. Lack of PA is a significant risk factor for\n      sarcopenia. Vitamin D plays an important role on bone and muscle development.\n\n      This study was conducted to determine the prevalence of sarcopenia and to evaluate the\n      effectiveness of PA and vitamin D supplementation in enhancing muscle mass and strength in\n      community-dwelling older adults with osteopenia /osteoporosis.\\ One hundred and forty-five\n      individuals aged 65 years and above with documented osteopenia/osteoporosis were scanned for\n      sarcopenia (defined as a relative skeletal muscle index (appendicular skeletal muscle mass\n      divided by height) below 5.45 kg/m2). The participants were randomly assigned to one of four\n      groups: Group 1-PA and vitamin D (n= 38), Group 2-PA(n=36), Group 3-vitamin D (n= 36) or\n      Group 4-healthy lifestyle(n =35) for 16 weeks. The PA group received a 60-minute 3-day/week\n      exercise programme, the vitamin D group received oral cholecalciferol 2000 IU/day and the\n      control group was provided with health education using videotaped presentations, physician\n      talks on topics concerning bone and muscle health. Body composition was measured by dual\n      energy X-ray absorptiometry (DEXA).  Vitamin D levels were measured by Liaison immunoassay.\n      PA was measured using the Baecke Physical Activity Questionnaire. Physical performance was\n      assessed using upper limb grip strength, walking speed and knee extension strength. All data\n      was collected at baseline and at 4 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  older adults aged 60 and above\n\n          -  osteopenia/osteoporosis\n\n        Exclusion Criteria:\n\n          -  severe cognitive impairment\n\n          -  major organ disease\n\n          -  current consumption of corticosteroids or vitamin D"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "145", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01666522", 
            "org_study_id": "alexmed116671002"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Vitamin D", 
                    "Vitamin D and Physical activity", 
                    "Control"
                ], 
                "description": "vitamin D given orally as tablets at a dosage of 2000 IU/day for 4 months", 
                "intervention_name": "Vitamin D", 
                "intervention_type": "Drug", 
                "other_name": "cholecalciferol"
            }, 
            {
                "arm_group_label": [
                    "Physical activity", 
                    "Vitamin D and Physical activity"
                ], 
                "description": "Physical activity in the form of an exercise programme consisting of 60 minutes all inclusive warming up , strengthening, resistance and stretching exercises were instigated 3 times a week for 4 months.", 
                "intervention_name": "Physical activity", 
                "intervention_type": "Other", 
                "other_name": "Exercise programme"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cholecalciferol", 
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "sarcopenia", 
            "osteopenia/osteoporosis", 
            "older adults", 
            "vitamin D supplementation", 
            "physical activity"
        ], 
        "lastchanged_date": "August 10, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Alexandria", 
                    "country": "Egypt", 
                    "zip": "00203"
                }, 
                "name": "Faculty of Medicine"
            }
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "4", 
        "official_title": "Effect of Vitamin D Supplementation and Physical Activity in Preventing Sarcopenia in Older Adults With Osteoporosis", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Egypt: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "muscle mass change", 
                "safety_issue": "Yes", 
                "time_frame": "4 months"
            }, 
            {
                "description": "To determine change in vitamin D status, fasting blood samples were collected from all participants at baseline and after 16 weeks of intervention and were measured by Liaison immunoassay.\nMuscle mass change and sarcopenia prevention was measured using the relative skeletal muscle index (appendicular skeletal muscle mass divided by height) below 5.45 kg/m2).", 
                "measure": "Muscle mass change", 
                "safety_issue": "Yes", 
                "time_frame": "4 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01666522"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Faculty of Medicine, University of Alexandria", 
            "investigator_full_name": "Anna Abou-Raya", 
            "investigator_title": "Professor of Rheumatology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Faculty of Medicine, University of Alexandria", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Faculty of Medicine, University of Alexandria", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}